发明名称 |
Anti-RSV immunogens and methods of immunization |
摘要 |
<p>Immunogenic polypeptides corresponding to one or more RSV G glycoproteins, or analogues thereof, are provided as components of vaccines. The inventive compositions are useful as both a prophylactic and therapeutic for the prevention and treatment of RSV infections and associated pulmonary or other diseases. The inventive immunogens include regions of the RSV G protein, specifically, amino acid residues 164-176 of RSV G A2 protein or analogues thereof. This inventive immunogen is operable alone or in combination with other polypeptides such as the RSV G protein amino acid residues 155-206, or other vaccines such as live RSV vaccines, or inactivated RSV vaccines or immunogenic analogues thereof.</p> |
申请公布号 |
AU2010279492(A1) |
申请公布日期 |
2012.03.01 |
申请号 |
AU20100279492 |
申请日期 |
2010.08.04 |
申请人 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY |
发明人 |
ANDERSON, LARRY J.;HAYNES, LIA M.;TRIPP, RALPH A. |
分类号 |
C07K14/115;A61K39/12;A61K39/155 |
主分类号 |
C07K14/115 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|